Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations

Jacob D. Soumerai, Ai Ni, Mohamed Darif, Anil Londhe, Guan Xing, Yong Mun, Neil E. Kay, Tait D. Shanafelt, Kari G. Rabe, John C. Byrd, Asher A. Chanan-Khan, Richard R. Furman, Peter Hillmen, Jeffrey Jones, John F. Seymour, Jeffrey P. Sharman, Lucille Ferrante, Mehrdad Mobasher, Thomas Stark, Vijay ReddyLyndah K. Dreiling, Pankaj Bhargava, Angela Howes, Danelle F. James, Andrew D. Zelenetz

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations'. Together they form a unique fingerprint.

Medicine & Life Sciences